In situ formation of poly (thiolated chitosan-co-alkylated β-cyclodextrin) hydrogels using click cross-linking for sustained drug release
Source abstract
Abstract
Despite their considerable potential, using in situ injectable hydrogels for drug delivery has some associated drawbacks. The ratio of precursor to reaction required for gelation is a relatively fine balance, and low strength makes the gel prone to plastic deformation. To improve gel strength, poly (thiolated chitosan-co-alkylated β-cyclodextrin) [poly (CS-SH-co-Alkynyl-β-CD)] hydrogels with high cross-linking density were first obtained by click chemistry. Chitosan and cyclodextrins are derived from natural polymers and can be modified with mercapto and alkynyl groups, respectively, to achieve gels with high cross-linking density. The physical properties of the gels were optimized by adjusting the mass ratio of thiolated chitosan and alkylated β-cyclodextrins. Experiments revealed that the in situ hydrogels exhibit good mechanical properties. Furthermore, the specific binding and controlled release of a model drug, bendamustine hydrochloride, were studied using in situ gels as carriers. The in situ hydrogel also exhibited excellent degradation. In situ mutual cross-linking poly (CS-SH-co-Alkynyl-β-CD) hydrogels are therefore an efficient drug delivery method requiring minimal invasive surgery, and have attractive application prospects in the treatment of solid tumors.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Hydrogels: synthesis, properties, applications · Advanced Drug Delivery Systems · Nanoparticle-Based Drug Delivery
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (46)
Show source-provided references
1. Cho EJ, Sun B, Doh KO, Wilson EM, Torregrosaallen S, Elzey BD, Yeo Y (2015) Intraperitoneal delivery of platinum with in situ crosslinkable hyaluronic acid gel for local therapy of ovarian cancer. Biomaterials 37:312–31910.1016/j.biomaterials.2014.10.039 ↗
2. Hu CH, Feng HZ, Zhu CY (2012) Preparation and characterization of rifampicin-PLGA microspheres/sodium alginate in situ gel combination delivery system. Colloid Surf B Biointerfaces 95:162–16910.1016/j.colsurfb.2012.02.030 ↗
3. Mahajan HS, Shah SK, Surana SJ (2011) Nasal in situ gel containing hydroxy propyl β-cyclodextrin inclusion complex of artemether: development and in vitro evaluation. J Incl Phenom Macrocycl Chem 70:49–5810.1007/s10847-010-9861-x ↗
4. Nair RV, Nair SC (2014) Cross linked chitosan in situ gel of Satranidazole for intra periodontal drug delivery. Int Res J Pharm 5:384–39110.7897/2230-8407.050580 ↗
5. Talasaz AHH, Ghahremankhani AA, Moghadam SH, Malekshahi MR, Atyabi F, Dinarvand R (2008) In situ gel forming systems of poloxamer 407 and hydroxypropyl cellulose or hydroxypropyl methyl cellulose mixtures for controlled delivery of vancomycin. J Appl Polym Sci 109:2369–237410.1002/app.28163 ↗
6. Jin HH, Lee CH, Lee WK, Lee JK, Park HC, Yoon SY (2008) In-situ formation of the hydroxyapatite/chitosan-alginate composite scaffolds. Mater Lett 62:1630–163310.1016/j.matlet.2007.09.043 ↗
7. Li FF, Liu Y, Ding Y, Xie QF (2014) A new injectable in situ forming hydroxyapatite and thermosensitive chitosan gel promoted by Na2CO3. Soft Matter 10:2292–230310.1039/C3SM52508B ↗
8. Yu ZG, Guo FX, Guo YY, Zhang ZR, Wu F, Luo XQ (2017) Optimization and evaluation of astragalus polysaccharide injectable thermoresponsive in situ gels. PLoS ONE 12(3):e0173949. https://doi.org/10.1371/journal.pone.017394910.1371/journal.pone.0173949 ↗
9. Overstreet DJ, Dutta D, Stabenfeldt SE, Vernon BL (2012) Injectable hydrogels. J Polym Sci B Polym Phys 50:881–90310.1002/polb.23081 ↗
10. Bowman BN, Hoyle C (2010) Thiol-ene click chemistry. Angew Chem Int Ed 49:1540–157310.1002/anie.200903924 ↗
11. Kamata H, Akagi Y, Kayasuga-Kariya Y, Chung U, Sakai T (2014) ”Nonswellable” hydrogel without mechanical hysteresis. Science 343:873–87510.1126/science.1247811 ↗
12. Truong VX, Ablett MP, Richardson SM, Hoyland JA, Dove AP (2015) Simultaneous orthogonal dual-click approach to tough, in situ-forming hydrogels for cell encapsulation. J Am Chem Soc 137:1618–162210.1021/ja511681s ↗
13. Constantin M, Bucatariu S, Ascenzi P, Simionescu BC, Fundueanu G (2014) Poly(NIPAAm-co-β-cyclodextrin) microgels with drug hosting and temperature-dependent delivery properties. React Funct Polym 84:1–910.1016/j.reactfunctpolym.2014.07.024 ↗
14. Sun SJ, Liu WG, Cheng N (2005) A thermoresponsive Chitosan-NIPAAm/Vinyl laurate copolymer vector for gene transfection. Bioconjugate Chem 16:972–98010.1021/bc0500701 ↗
15. Yang JM, Lin HT (2004) Properties of chitosan containing PP-g-AA-g-NIPAAm bigraft nonwoven fabric for wound dressing. J Membr Sci 243:1–710.1016/j.memsci.2004.03.019 ↗
16. Parrish B, Breitenkamp RB, Emrick T (2005) PEG-and peptide-grafted aliphatic polyesters by click chemistry. J Am Chem Soc 127:7404–741010.1021/ja050310n ↗
17. Seliktar D (2012) Designing cell-compatible hydrogels for biomedical applications. Science 336(6085):1124–112810.1126/science.1214804 ↗
18. Bernkop-Schnürch A, Hornof M, Guggi D (2004) Thiolated chitosans. Eur J Pharm Biopharm 57:9–1710.1016/S0939-6411(03)00147-4 ↗
19. Zhang L, Wang L, Guo BL, Ma PX (2014) Cytocompatible injectable carboxymethyl chitosan/N-isopropylacrylamide hydrogels for localized drug delivery. Carbohydr Polym 103:110–11810.1016/j.carbpol.2013.12.017 ↗
20. Snyder GH, Reddy MK, Cennerazzo MJ, Field D (1983) Use of local electrostatic environments of cysteines to enhance formation of a desired species in a reversible disulfide exchange reaction. Biochim Biophys Acta 749:219–22610.1016/0167-4838(83)90228-5 ↗
21. Fairbanks BD, Scott TF, Kloxin CJ, Anseth KS, Bowman CN (2009) Thiol–yne photopolymerizations: novel mechanism, kinetics, and step-growth formation of highly cross-linked networks. Macromolecules 42:211–21710.1021/ma801903w ↗
22. Ganivada MN, Kumar P, Shunmugam R (2015) Unique polymeric gel by thiol-alkyne click chemistry. RSC Adv 5:50001–5000410.1039/C5RA06339F ↗
23. Cao YX, Zhang C, Shen WB, Cheng ZH, Yu LL, Ping QN (2007) Poly (N-isopropylacrylamide)-chitosan as thermosensitive in situ gel-forming system for ocular drug delivery. J Control Release 120:186–19410.1016/j.jconrel.2007.05.009 ↗
24. Lai JY, Luo LJ (2017) Chitosan-g-poly (N-isopropylacrylamide) copolymers as delivery carriers for intracameral pilocarpine administration. Eur J Pharm Biopharm 113:140–14810.1016/j.ejpb.2016.11.038 ↗
25. Gaffar MA, El-Rafie SM, El-Tahlawy KF (2004) Preparation and utilization of ionic exchange resin via graft copolymerization of β-CD itaconate with chitosan. Carbohydr Polym 56:387–39610.1016/j.carbpol.2004.01.007 ↗
26. Ibrahim NA, E-Zairy WR, Eid BM (2010) Novel approach for improving disperse dyeing and UV-protective function of cotton-containing fabrics using MCT-β-CD. Carbohydr Polym 79:839–84610.1016/j.carbpol.2009.10.008 ↗
27. Jin L, Liu Q, Sun ZY, Ni XY, Wei M (2010) Preparation of 5-fluorouracil/beta-cyclodextrin complex intercalated in layered double hydroxide and the controlled drug release properties. Ind Eng Chem Res 49:11176–1118110.1021/ie100990z ↗
28. Loethen S, Kim JM, Thompson DH (2007) Biomedical applications of cyclodextrin based polyrotaxanes. Polym Rev 47:383–41810.1080/15583720701455145 ↗
29. Ellman GL, Courtney KD, Andres V Jr, Feather-Stone RM (1961) A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 71:88–9510.1016/0006-2952(61)90145-9 ↗
30. Gidwani B, Vyasa A (2015) Inclusion complexes of bendamustine with β-CD, HP-β-CD and Epi-β-CD: in vitro and in vivo evaluation. Drug Dev Ind Pharm 41:1978–198810.3109/03639045.2015.1027217 ↗
31. Chiou BS, Khan SA (1997) Real-time FTIR and in situ rheological studies on the UV curing kinetics of thiol-ene polymers. Macromolecules 30:7322–732810.1021/ma9708656 ↗
32. Crichton ML, Chen X, Huang H, Kendall MA (2013) Elastic modulus and viscoelastic properties of full thickness skin characterised at micro scales. Biomaterials 34:2087–209710.1016/j.biomaterials.2012.11.035 ↗
33. Sakai S, Liu Y, Matsuyama T, Kawakami K, Taya M (2012) On-demand serum-degradable amylopectin-based in situ gellable hydrogel. J Mater Chem 22:1944–194910.1039/C1JM14460J ↗
34. Wang KK, Jia QA, Han F, Liu HZ, Li SM (2010) Self-assembled l-alanine derivative organogel as in situ drug delivery implant: characterization, biodegradability, and biocompatibility. Drug Dev Ind Pharm 36:1511–152110.3109/03639045.2010.488694 ↗
35. Lin HL, Lin SY, Lin CC, Hsu CH, Wu TK, Huang YT (2012) Mechanical grinding effect on thermodynamics and inclusion efficiency of loratadine-cyclodextrin inclusion complex formation. Carbohydr Polym 87:512–51710.1016/j.carbpol.2011.08.010 ↗
36. Kast CE, Bernkop-Schnürch A (2001) Thiolated polymers-thiomers: development and in vitro evaluation of chitosan-thioglycolic acid conjugates. Biomaterials 22:2345–235210.1016/S0142-9612(00)00421-X ↗
37. Mahmood A, Lanthaler M, Laffleur F, Huck CW, Bernkopschnürch A (2017) Thiolated chitosan micelles: highly mucoadhesive drug carriers. Carbohydr Polym 167:250–25810.1016/j.carbpol.2017.03.019 ↗
38. Mark JE (1982) Experimental determinations of crosslink densities. Rubber Chem Technol 55:762–76810.5254/1.3535902 ↗
39. Izadi Z, Divsalar A, Saboury AA, Sawyer L (2016) β-lactoglobulin-pectin nanoparticle-based oral drug delivery system for potential treatment of colon cancer. Chem Biol Drug Des 88:209–21610.1111/cbdd.12748 ↗
40. Manzoori JL, Amjadi M (2003) Spectrofluorimetric study of host-guest complexation of ibuprofen with beta-cyclodextrin and its analytical application. Spectrochim Acta Part A Mol Biomol Spectrosc 59:909–91610.1016/S1386-1425(02)00295-0 ↗
41. Friedberg JW, Cohen P, Chen L (2008) Bendamustine in patients with rituximab-refractory indolent and transformed non-Hodgkin’s lymphoma: results from a phase II multicenter, single-agent study. J Clin Oncol 26:1911. https://doi.org/10.1200/JCO.2007.12.507010.1200/JCO.2007.12.5070 ↗
42. Kahl BS, Bartlett NL, Leonard JP (2010) Bendamustine is effective therapy in patients with rituximab-refractory, indolent B-cell non-Hodgkin lymphoma: results from a multicenter study. Cancer 116:106–11410.1002/cncr.24714 ↗
43. Rummel MJ, Al-Batran SE, Kim SZ (2005) Bendamustine plus rituximab is effective and has a favorable toxicity profile in the treatment of mantle cell and low-grade non-Hodgkin’s lymphoma. J Clin Oncol 23:3383–338910.1200/JCO.2005.08.100 ↗
44. Gidwani B, Vyas A (2015) Designing and evaluation of extended release matrix tablet containing altretamine-HP-β-CD inclusion complex. J Incl Phenom Macrocycl Chem 83:401–40910.1007/s10847-015-0569-9 ↗
45. Uekama K, Hirayama F, Irie T (1998) Cyclodextrin drug carrier systems. Chem Rev 98(5):2045–207610.1021/cr970025p ↗
46. Stella VJ, Rao VM, Zannou EA, Zia V (1999) Mechanisms of drug release from cyclodextrin complexes. Adv Drug Deliv Rev 36(1):3–1610.1016/S0169-409X(98)00052-0 ↗